An alternative approach for the conversion of aldehydes to terminal alkynes
Z Wang, J Yin, S Campagna, JA Pesti…
Index: Wang, Zhe; Yin, Jianguo; Campagna, Silvio; Pesti, Jaan A.; Fortunak, Joseph M. Journal of Organic Chemistry, 1999 , vol. 64, # 18 p. 6918 - 6920
Full Text: HTML
Citation Number: 26
Abstract
Efavirenz (Sustiva, DMP 266) is a nonnucleoside reverse transcriptase inhibitor of the HIV-1 virus developed by our company for the treatment of AIDS. This compound demonstrates superior antiretroviral activity and has been approved for use as an anti-HIV agent in the US Our enantioselective synthesis of Efavirenz1 employs cyclopropylacetylene (1), which is expensive and difficult to obtain. The existing preparations of 1 require either 5-chloro-1- ...
Related Articles:
[Lyapkalo, Ilya M.; Vogel, Michael A. K.; Boltukhina, Ekaterina V.; Vavrik, Jiri Synlett, 2009 , # 4 p. 558 - 561]
[Kimura, Yoshikazu; Regen, Steven L. Journal of Organic Chemistry, 1982 , vol. 47, # 12 p. 2493 - 2494]
[Beshai, Mira; Dhudshia, Bhartesh; Mills, Ryan; Thadani, Avinash N. Tetrahedron Letters, 2008 , vol. 49, # 48 p. 6794 - 6796]
[Shchelkunov; Sivolobova; Mataeva; Minbaev; Muldakhmetov Russian Journal of Organic Chemistry, 2001 , vol. 37, # 1 p. 5 - 8]
[Bioorganic and Medicinal Chemistry Letters, , vol. 15, # 9 p. 2243 - 2247]